SYRS
Syros Pharmaceuticals, Inc. Common Stock
SYRS
SYRS
Delisted
SYRS was delisted on the 19th of March, 2025.
68 hedge funds and large institutions have $124M invested in Syros Pharmaceuticals, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 8 funds opening new positions, 25 increasing their positions, 22 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
68
Holders Change
-8
Holders Change %
-10.53%
% of All Funds
1.52%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
8
Increased
25
Reduced
22
Closed
16
Calls
$85K
Puts
–
Net Calls
+$85K
Net Calls Change
-$100K
Top Buyers
| 1 |
BlackRock
New York
|
+$2.07M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$1.33M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
+$881K |
| 4 |
Renaissance Technologies
New York
|
+$537K |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$522K |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$2.03M |
| 2 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
-$1.79M |
| 3 |
PP
PDT Partners
New York
|
-$618K |
| 4 |
Millennium Management
New York
|
-$427K |
| 5 |
VEA
Virtus ETF Advisers
New York
|
-$424K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
MLICM
76
Metropolitan Life Insurance Company (MetLife)
New York
| – | -$110K | -926 | Closed |
|
77
Acadian Asset Management
Boston,
Massachusetts
| – | -$66K | -553 | Closed |
|
78
US Bancorp
Minneapolis,
Minnesota
| – | -$12K | -100 | Closed |
|
|
AG
79
Advisor Group
Phoenix,
Arizona
| – | -$12K | -100 | Closed |
|
80
BNP Paribas Financial Markets
Paris,
France
| – | -$8.66K | -73 | Closed |
|
81
Group One Trading
Chicago,
Illinois
| – | -$4K | -32 | Closed |
|
|
KF
82
Krilogy Financial
St. Louis,
Missouri
| – | -$1K | -10 | Closed |
|
|
HR
83
Howe & Rusling
Rochester,
New York
| – | -$1K | -5 | Closed |
|